The Conference Forum has announced the launch of the 2nd annual Clinical Trial Collaborations (CTC) conference in Boston on April 3-4, 2017.
Led by Co-Chair Katherine Vandebelt, Global Head of Clinical Innovation at Eli Lilly, the CTC conference is the only strategic-level event in the U.S. entirely focused on collaborations needed for 21st century drug development.
Valerie Bowling, executive director of the CTC event, said, “The future of collaborations in drug development will require partners we never thought of before and new models for outstanding project delivery.”
The CTC conference offers a variety of sessions that illustrate new collaboration techniques to drive improved clinical trial outcomes and bring clinical trial professionals closer to patients. Ken Getz, director of Sponsored Research Programs at Tufts CSDD, will kick off the event with a presentation titled, “How the Clinical Collaborations Landscape Is Changing and Its Impact on R&D Operations.” The CTC conference will also feature three first-time keynote presentations:
Takeda on their Transformational Clinical Development and Marketed Product Partnership with PRA Health Sciences with Dr. Andy Plump, director, chief medical and scientific officer, Takeda
Models for Exquisite Project Delivery with Internal and External Partners with Dr. Andy Lee, senior vice president, head of Global Clinical Trial Operations, Merck
Big Trends Impacting Clinical Development with Dr. Steve Cutler, chief operating officer and CEO Designate, ICON
In addition, the CTC conference will feature:
Technology Needs and Solutions Discussion: Judith Dunn, vice president, global head of Clinical Development and head of Innovation Center at Roche, will lead an interactive session on identifying technology needs and solutions.
Partnering Tool: All conference attendees can access a partnering tool and partnering facilities to host small group and one-on-one meetings.
Clinical Research as a Care Option: This collaborative session scheduled for the entire afternoon of April 4 shows us how clinical trial professionals can bring patients closer to clinical research and can find ways to make clinical trials a care option. It is considered one of the biggest topics for the future of healthcare. Dr. John McConnell, CEO, Wake Forest University Medical, is confirmed to keynote this section of the conference.
The CTC conference offers presentations that deliver insightful clinical trial ideas and challenges for R&D operations, CROs and site executives. It serves as an ideal event for senior-level clinical operation executives from large, medium and small pharmas, CROs, sites and patient advocacy organizations.
